CJC-1295 (with DAC)

CJC-1295 (with DAC) is a modified growth hormone-releasing hormone (GHRH) analog that has become a valuable compound in endocrine and peptide research due to its extended duration of activity. Researchers study CJC-1295 (with DAC) to better understand sustained growth hormone–related signaling, pituitary regulation, endocrine physiology, protein metabolism, and long-term receptor activation under controlled laboratory conditions. Its prolonged half-life, achieved through the Drug Affinity Complex (DAC), makes it a widely investigated peptide for research examining the effects of extended GHRH pathway stimulation and downstream biological responses.

• Designed for laboratory research involving peptide function and cellular signaling
• Lyophilized powder for consistent preparation and experimental handling
• Manufactured to pharmaceutical-grade quality standards for dependable research applications
• Vial Size: 3 mL

For laboratory research use only. Not for human consumption.